POSSIBILITIES OF OVARIAL SUPPRESSION IN HORMONE-DEPENDENT MAMMARY GLAND CANCER
Ovarian suppression (OS) is an effective therapy in hormone-sensitive breast cancer. Oophorectomy and ovarian irradiation have historically been used to achieve the goal of ovarian ablation. Luteinizing hormone releasing hormone (LHRH) analogues have largely supplanted surgical and radiation-based a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-06-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1901 |
_version_ | 1797842035619659776 |
---|---|
author | I. A. KOROLEVA M. V. KOPP |
author_facet | I. A. KOROLEVA M. V. KOPP |
author_sort | I. A. KOROLEVA |
collection | DOAJ |
description | Ovarian suppression (OS) is an effective therapy in hormone-sensitive breast cancer. Oophorectomy and ovarian irradiation have historically been used to achieve the goal of ovarian ablation. Luteinizing hormone releasing hormone (LHRH) analogues have largely supplanted surgical and radiation-based approaches because of less side effects and a lower likelihood of permanent amenorrhea, with the potential for restoration of fertility. LHRH analogues goserelin, buserelin, leuprorelin are equally effective. Buserelin is economically attractive. |
first_indexed | 2024-04-09T16:41:21Z |
format | Article |
id | doaj.art-54bf1339d3cc477fa9e0c860266ca760 |
institution | Directory Open Access Journal |
issn | 2079-701X 2658-5790 |
language | Russian |
last_indexed | 2024-04-09T16:41:21Z |
publishDate | 2017-06-01 |
publisher | Remedium Group LLC |
record_format | Article |
series | Медицинский совет |
spelling | doaj.art-54bf1339d3cc477fa9e0c860266ca7602023-04-23T06:56:40ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902017-06-010615215510.21518/2079-701X-2017-6-152-1551878POSSIBILITIES OF OVARIAL SUPPRESSION IN HORMONE-DEPENDENT MAMMARY GLAND CANCERI. A. KOROLEVA0M. V. KOPP1Medical University ReavizMedical University ReavizOvarian suppression (OS) is an effective therapy in hormone-sensitive breast cancer. Oophorectomy and ovarian irradiation have historically been used to achieve the goal of ovarian ablation. Luteinizing hormone releasing hormone (LHRH) analogues have largely supplanted surgical and radiation-based approaches because of less side effects and a lower likelihood of permanent amenorrhea, with the potential for restoration of fertility. LHRH analogues goserelin, buserelin, leuprorelin are equally effective. Buserelin is economically attractive.https://www.med-sovet.pro/jour/article/view/1901metastatic breast cancerhormone therapyovarian suppressionovarian ablationoophorectomyirradiation of ovarieslhrh analoguebuserelin |
spellingShingle | I. A. KOROLEVA M. V. KOPP POSSIBILITIES OF OVARIAL SUPPRESSION IN HORMONE-DEPENDENT MAMMARY GLAND CANCER Медицинский совет metastatic breast cancer hormone therapy ovarian suppression ovarian ablation oophorectomy irradiation of ovaries lhrh analogue buserelin |
title | POSSIBILITIES OF OVARIAL SUPPRESSION IN HORMONE-DEPENDENT MAMMARY GLAND CANCER |
title_full | POSSIBILITIES OF OVARIAL SUPPRESSION IN HORMONE-DEPENDENT MAMMARY GLAND CANCER |
title_fullStr | POSSIBILITIES OF OVARIAL SUPPRESSION IN HORMONE-DEPENDENT MAMMARY GLAND CANCER |
title_full_unstemmed | POSSIBILITIES OF OVARIAL SUPPRESSION IN HORMONE-DEPENDENT MAMMARY GLAND CANCER |
title_short | POSSIBILITIES OF OVARIAL SUPPRESSION IN HORMONE-DEPENDENT MAMMARY GLAND CANCER |
title_sort | possibilities of ovarial suppression in hormone dependent mammary gland cancer |
topic | metastatic breast cancer hormone therapy ovarian suppression ovarian ablation oophorectomy irradiation of ovaries lhrh analogue buserelin |
url | https://www.med-sovet.pro/jour/article/view/1901 |
work_keys_str_mv | AT iakoroleva possibilitiesofovarialsuppressioninhormonedependentmammaryglandcancer AT mvkopp possibilitiesofovarialsuppressioninhormonedependentmammaryglandcancer |